Docs, vendors pursue common ground for telehealth regulation in Texas

Person typing on a computer

After years of legal wrangling over telemedicine regulation in Texas, representatives of healthcare organizations and telemedicine companies met this week to hash out a compromise, according to the Texas Tribune.

Lobbyists described the closed-door meeting as a discussion on "modernizing our telemedicine statutes and reducing the regulatory footprint governing the provision of telemedicine services," the article said. 

Last year, lawmakers passed a requirement that patients must meet face to face with a physician before the use of telemedicine to prescribe medications. The Texas Medical Board and telemedicine provider Teledoc have been arguing in court since 2011 over that in-person requirement.

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

Tom Banning, chief executive of the Texas Academy of Family Physicians, described the meeting as a result of "thawing of tensions" between doctors and telemedicine vendors, the Tribune reported. That's been attributed to new technologies that have made remote doctor-patient interaction easier.

The groups reportedly are looking at Indiana's law as a model: It does not require an initial in-person visit as long as remote telemedicine consultations meet certain standards of care.

To learn more:
- here's the article

Read more on

Suggested Articles

The Oregon Department of Human Services confirmed on Thursday a data breach due to a phishing email incident that compromised and potentially exposed the…

FDA Commissioner Scott Gottlieb on Wednesday called for tighter scrutiny of electronic health records systems.

While UPS didn't say which vaccine it would be using in the project, Reuters confirmed with pharma giant Merck that it is looking at participating.